Daniel Sentana‐Lledo

Also affiliated with Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates”.

EGFR exon 20 insertion mutations and ERBB2 mutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates

Translational Lung Cancer Research(2023)10.21037/tlcr-23-98

N/A

0DataRank · unranked

33 citations

Emmeline C. Academia, Hollis Viray, Deepa Rangachari, Susumu Kobayashi, Paul A. VanderLaan +2 more

EGFR exon 19 insertion EGFR-K745_E746insIPVAIK and others with rare XPVAIK amino-acid insertions: Preclinical and clinical characterization of the favorable therapeutic window to all classes of approved EGFR kinase inhibitors

Lung Cancer(2023)10.1016/j.lungcan.2023.107250

N/A

0DataRank · unranked

6 citations

Ikei S. Kobayashi, Daniel Sentana‐Lledo, Shriram K. Sundararaman, Meghan Lee, Deepa Rangachari +4 more

Prevalence and Morbidity of Local Treatment-Related Side Effects in Metastatic Prostate Cancer Patients

Urologic Oncology Seminars and Original Investigations(2023)10.1016/j.urolonc.2023.01.012

N/A

0DataRank · unranked

3 citations

Laura E. Dodge, Peter Chang, David J. Einstein, Daniel Sentana‐Lledo

Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)

European Urology Oncology(2024)10.1016/j.euo.2024.04.010

N/A

0DataRank · unranked

8 citations

Xiangying Chu, David F. Jarrard, Michael A. Carducci, Robert S. DiPaola, Lynn I. Wagner +4 more

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.003

N/A

0DataRank · unranked

1 citations

Xiangying Chu, Charles J. Ryan, Arjun Gupta, Christopher J. Sweeney, David F. Jarrard +10 more